Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

89.07 +4.98 (+5.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
32 33 Next >
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year. 
Via Investor's Business Daily
Two Hot AI Stocks Lead S&P 500 Monday
Super Micro and Micron , two big winners in 2024, led the way Monday. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
Via Benzinga
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio. 
Via InvestorPlace
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
DexCom, Blackstone and Royal Caribbean head this list of five stocks. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
DexCom's Options: A Look at What the Big Money is Thinking
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
DexCom Stock Trying To Close In On Key Technical Benchmark
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says
DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC) 
Via Benzinga
Analyst Expectations For DexCom's Future
Via Benzinga
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout. 
Via Chartmill
ServiceNow Setting Up As Three Stocks Flash Buy Signals
All four stocks to watch boast solid earnings growth. 
Via Investor's Business Daily
2 Medical Device Stocks to Buy Hand Over Fist in March
Don't let their modest gains over the past year mislead you; these stocks can make for great long-term investments. 
Via The Motley Fool
Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. 
Via Benzinga
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant... 
Via Benzinga
Exposures Product Safety
Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday?
Markets rallied across the board on Wednesday, erasing the uptick in volatility seen in the previous session, following reassurances from Fed Chair Jerome Powell regarding the Fed’s willingness to ease... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it. 
Via Investor's Business Daily
Exposures Product Safety
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
FDA-approved Dexcom Stelo: Over-the-counter glucose monitoring for non-insulin users. Stelo, the first OTC CGM, available online without prescription from summer 2024. Continuous glucose tracking with... 
Via Benzinga
Exposures Product Safety
Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
From DexCom, Inc.
Via Business Wire
Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move
With patience, these stocks will provide outsized returns to investors. 
Via The Motley Fool
Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla
U.S. stock market continues bull run, hitting record highs for S&P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones. 
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
3 Telehealth Stocks With Room to Run in 2024
Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio. 
Via InvestorPlace
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
DexCom: A Winner In Diabetes Management
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820... 
Via Talk Markets
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode. 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.